We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

8 hedge funds and large institutions have $67M invested in Bionano Genomics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.15% more ownership

Funds ownership: 0% → 0.15% (+0.15%)

Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$50.6M
2
SCM
Sio Capital Management
New York
+$10.2M
3
Walleye Trading
Walleye Trading
New York
+$674K
4
PCM
Perkins Capital Management
Minnesota
+$350K
5
Victory Capital Management
Victory Capital Management
Texas
+$59.7K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$56.7M +$50.6M +11,868 New
SCM
2
Sio Capital Management
New York
$7.35M +$10.2M +2,401 New
MIM
3
Monashee Investment Management
Massachusetts
$1.3M – – –
Walleye Trading
4
Walleye Trading
New York
$756K +$674K +158 New
Walleye Capital
5
Walleye Capital
New York
$417K +$371K +87 New
PCM
6
Perkins Capital Management
Minnesota
$390K +$350K +82 New
Victory Capital Management
7
Victory Capital Management
Texas
$65K +$59.7K +14 New
WVP
8
Worth Venture Partners
New Jersey
$34K +$34.1K +8 New
Morgan Stanley
9
Morgan Stanley
New York
$2K +$4.26K +1 New

BNGO Hedge Fund Activity: Q3 2018 in Review

8 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2018, worth a combined $67M.

Buyers outnumbered sellers: 8 funds opened new BNGO positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Federated Hermes, opening a new position worth an estimated $50.6M.

  • 8 institutional investors held Bionano Genomics (BNGO) as of Q3 2018, up from 0 in Q2 2018.
  • Funds reported $67M of Bionano Genomics stock for Q3 2018.
  • 8 funds opened new Bionano Genomics positions in Q3 2018 and 0 closed out, a net change of +8 holders.
  • The largest Bionano Genomics buyer in Q3 2018 was Federated Hermes, an estimated $50.6M added.

Based on aggregated 13F filings for Q3 2018.